Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDivislaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Bull's Eye: Buy Apollo Tyres, Biocon, Idea, YES Bank

      Krish Subramanium of Asit C Mehta Investment advises buying Biocon for a target price of Rs 485 and CESC for a target price of Rs 472.

    • Buy Divis Laboratories on correction: Abhishek Karande

      Abhishek Karande of SBI Capital Securities is of the view that one may buy Divis Laboratories on correction as the stock may touch Rs 1400.

    • Divis Laboratories may test Rs 1375-1400: Vishal Malkan

      Vishal Malkan of malkansview.com prefers Divis Laboratories within the pharma space and feels that the stock may test Rs 1375-1400.

    • Buy Lupin, Cipla, Dr Reddys Lab: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com advises buying Lupin, Divis Laboratories, Sun Pharmaceutical Industries, Cipla and Dr Reddys Laboratories.

    • Buy Divis Laboratories: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may buy Divis Laboratories.

    • Bull's Eye: Buy Amara Raja, Tata Chemicals; short RComm

      Sharmila Joshi of sharmilajoshi.com advises buying Amara Raja Batteries for a target price of Rs 346 and Jyothy Laboratories for a target price of Rs 199.

    • Super Six intraday picks for the day

      Vishal Malkan, CMT suggests buying Divis Laboratories with a target of Rs 1255-1270 and JSW Steel with a target of Rs 1040-1050.

    • Buy Cipla, Divis Laboratories: SP Tulsian

      SP Tulsian of sptulsian.com is of the view that one may buy Cipla and Divis Laboratories.

    • Prefer Divis Labs, Ranbaxy, Maruti: Abhishek Karande

      Abhishek Karande of SBICAP Securities is of the view that one may prefer Cipla, Divi‘s Laboartories, Ranbaxy Laboratories within the pharmaceutical sector, and Maruti Suzuki India and Hero Motocorp within the automobile space.

    • Bullish on Lupin, Aurobindo; cautious on Ranbaxy: Religare

      Arvind Bothra, vice president of institutional research at Religare Capital Markets is cautious on Ranbaxy because the earnings visibility is very low and believes that the expectations of a turnaround in the US business etc are seemingly priced-in the stock.

    • Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra

      Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top picks in the pharma space.

    • B Krishnakumar positive on Divis Laboratories

      B Krishnakumar, head- equity research at fundsindia.com is positive on Divis Laboratories. "The stock may test Rs 1400," he adds.

    • Divis Labs may test Rs 1230, says Hemant Thukral

      According to Hemant Thukral of Aditya Birla Money Divis Laboratories may touch Rs 1230.

    • Buy Divis Laboratories: Shubham Agarwal

      Shubham Agarwal, Head - Technical Research of Motilal Oswal Securities recommends buying Divis Laboratories with a target of Rs 1300 and a stoploss of Rs 1080.

    • Buy Dena Bank, Cadila Health, TNPL, Divis Labs: Prabhakar

      AK Prabhakar, Independent Advisor recommends buying Dena Bank with a target price of Rs 63 and Cadila Healthcare with a target price of Rs 815.

    • Bull's Eye: Buy Tech Mahindra, Titan, TNPL, Apollo Tyres

      Ashish Kapur of Investshoppe advises buying Tech Mahindra for a target price of Rs 1,795 and Apollo Tyres for a target price of Rs 87.

    • Buy Arvind, Divis Labs, Reliance Infra, JSW Energy: Malkan

      Vishal Malkan of malkansview.com recommends buying JSW Energy with a target of Rs 57 and Reliance Infrastructure with a target of Rs 455.

    • Bull's Eye: Buy Dabur, JSW Energy, Bata, Indian Hotel

      Nooresh Merani of Analyse India advises buying Mcleod Russel for a target price of Rs 320 and Bata India for a target price of Rs 1,080.

    • Sell Divis Laboratories: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling Divis Laboratories.

    • Buy Divis Labs, YES Bank, BOI, Reliance Cap: Malkan

      Vishal Malkan of malkansview.com recommends buying Divis Laboratories with a target of Rs 1195 and YES Bank with a target of Rs 415.

    • Bull's Eye: Buy Adani Power, Bank of India, Jain Irrigation

      Vishal Malkan of malkansview.com advises buying Divis Labs for a target price of Rs 1,195 and YES Bank for a target price of Rs 415.

    • Super Six short term picks for December 05

      Hemen Kapadia of KR Choksey Securities advises selling Divis Laboratories with a target of Rs 1122 and buying Wipro with a target of Rs 499.

    • Go long on Divis Laboratories: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends going long on Divis Laboratories.

    • Expect Divis Labs to touch Rs 1220, says Abhijit Paul

      Abhijit Paul, founder of Alphative Advisors is of the view that Divis Laboratories may touch Rs 1220 in the short term.

    • Buy Divis Laboratories: Vishal Malkan

      Vishal B Malkan of malkansview.com recommends buying Divis Laboratories as the stock may test Rs 1250.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347